Risk factors for extensive drug-resistance and mortality in geriatric inpatients with bacteremia caused by Acinetobacter baumannii

被引:45
作者
Fu, Qiang [1 ]
Ye, Huan [1 ]
Liu, Shumei [2 ]
机构
[1] Capital Med Univ, Dept Infect Dis, FuXing Hosp, Beijing 100038, Peoples R China
[2] Capital Med Univ, Dept Microbiol & Clin Lab, FuXing Hosp, Beijing 100038, Peoples R China
关键词
Acinetobacter baumannii; Bacteremia; Extensive drug resistance; Risk factors; Geriatric inpatients; CLINICAL-OUTCOMES; CARBAPENEM RESISTANCE; INFECTIONS;
D O I
10.1016/j.ajic.2015.03.033
中图分类号
R1 [预防医学、卫生学];
学科分类号
100235 [预防医学];
摘要
Background: The aim of this study was to explore the risk factors for developing bacteremia caused by extensive drug-resistant (XDR) Acinetobacter baumannii and the associated mortality in geriatric inpatients. Methods: We conducted a retrospective study of 125 patients with A baumannii bacteremia between October 2008 and December 2013 at a medical center in China. Results: The 30-day hospital mortality rate was 55.2%. XDR A baumannii was detected in 31.2% of all cases. A logistic regression analysis suggested that chronic obstructive pulmonary disease, a bedridden status, and central venous catheters were associated with bacteremia caused by XDR A baumannii, with adjusted odds ratios (aORs) and 95% confidence intervals (CIs) of 2.59 (1.01-6.64), 4.08 (1.39-12.01), and 9.52 (1.90-47.56), respectively. Furthermore, intensive care unit (ICU) stay, bacteremia caused by XDR A baumannii, concurrent fungal infection, and age (70-80 years old and >80 years old) were associated with mortality, with aORs and 95% CIs of 3.16 (1.29-7.73), 4.01 (1.46-11.04), 3.20 (1.28-7.98), 4.31 (1.44-12.92), and 5.46 (1.94-15.35), respectively. Conclusion: Bacteremia is associated with a high 30-day hospital mortality rate in geriatric inpatients. Furthermore, ICU stay, bacteremia caused by XDR A baumannii, concurrent fungal infection, and age are associated with increased mortality in geriatric inpatients with A baumannii bacteremia. Copyright (C) 2015 by the Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:857 / 860
页数:4
相关论文
共 14 条
[1]
Abbott I, 2013, EXPERT REV ANTI-INFE, V11, P395, DOI [10.1586/ERI.13.21, 10.1586/eri.13.21]
[2]
[Anonymous], M100S20 CLIN LAB STA
[3]
Anunnatsiri S, 2011, SE ASIAN J TROP MED, V42, P693
[4]
Epidemiology of Bloodstream Infections Caused by Acinetobacter baumannii and Impact of Drug Resistance to both Carbapenems and Ampicillin-Sulbactam on Clinical Outcomes [J].
Chopra, Teena ;
Marchaim, Dror ;
Awali, Reda A. ;
Krishna, Amar ;
Johnson, Paul ;
Tansek, Ryan ;
Chaudary, Khawar ;
Lephart, Paul ;
Slim, Jessica ;
Hothi, Jatinder ;
Ahmed, Harris ;
Pogue, Jason M. ;
Zhao, Jing J. ;
Kaye, Keith S. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (12) :6270-6275
[5]
Risk factors and clinical outcomes of patients with carbapenem-resistant Acinetobacter baumannii bacteremia [J].
Huang, Shih-Tse ;
Chiang, Mei-Chun ;
Kuo, Shu-Chen ;
Lee, Yi-Tzu ;
Chiang, Tong-Hong ;
Yang, Su-Pen ;
Ti-Yin ;
Chen, Te-Li ;
Fung, Chang-Phone .
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2012, 45 (05) :356-362
[6]
Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis [J].
Lemos, E. V. ;
de la Hoz, F. P. ;
Einarson, T. R. ;
McGhan, W. F. ;
Quevedo, E. ;
Castaneda, C. ;
Kawai, K. .
CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 (05) :416-423
[7]
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance [J].
Magiorakos, A. -P. ;
Srinivasan, A. ;
Carey, R. B. ;
Carmeli, Y. ;
Falagas, M. E. ;
Giske, C. G. ;
Harbarth, S. ;
Hindler, J. F. ;
Kahlmeter, G. ;
Olsson-Liljequist, B. ;
Paterson, D. L. ;
Rice, L. B. ;
Stelling, J. ;
Struelens, M. J. ;
Vatopoulos, A. ;
Weber, J. T. ;
Monnet, D. L. .
CLINICAL MICROBIOLOGY AND INFECTION, 2012, 18 (03) :268-281
[8]
A Multicenter Case-Case Control Study for Risk Factors and Outcomes of Extensively Drug-Resistant Acinetobacter baumannii Bacteremia [J].
Ng, Tat Ming ;
Teng, Christine B. ;
Lye, David C. ;
Apisarnthanarak, Anucha .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2014, 35 (01) :49-55
[9]
Ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii: Risk factors, clinical features, and outcomes [J].
Ozgur, Eylem Sercan ;
Horasan, Elif Sahin ;
Karaca, Kerem ;
Ersoz, Gulden ;
Atis, Sibel Nayci ;
Kaya, Ali .
AMERICAN JOURNAL OF INFECTION CONTROL, 2014, 42 (02) :206-208
[10]
Risk Factors for Mortality in Patients with Acinetobacter baumannii Bacteremia [J].
Park, Se Yoon ;
Choo, Jin Woo ;
Kwon, Soon Ha ;
Yu, Shi Nae ;
Lee, Eun Jung ;
Kim, Tae Hyong ;
Choo, Eun Ju ;
Jeon, Min Huok .
INFECTION AND CHEMOTHERAPY, 2013, 45 (03) :325-330